RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Manhattan Scientifics Stock

Manhattan Scientifics Stocks 2025

Manhattan Scientifics Stocks

559.28 M

Ticker

MHTX

ISIN

US5631221000

WKN

911936

In 2025, Manhattan Scientifics had 559.28 M outstanding stocks, a 0% change from the 559.28 M stocks in the previous year.

The Manhattan Scientifics Stocks history

YEARNUMBER OF STOCKS (M USD)
2023559.28
2022559.28
2021559.28
2020593.05
2019549.36
2018533.78
2017533.78
2016534.68
2015593.45
2014485.63
2013461.11
2012449.7
2011425.58
2010401.92
2009393.16
2008328.47
2007249.57
2006194.58
2005181.01
2004174.41

Manhattan Scientifics shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Manhattan Scientifics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Manhattan Scientifics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Manhattan Scientifics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Manhattan Scientifics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Manhattan Scientifics Aktienanalyse

What does Manhattan Scientifics do?

Manhattan Scientifics Inc is an innovative company that operates in the world of science and technology. The company was founded in 1994 by Marvin Maslow and is based in New York City. It primarily focuses on developing advanced technologies in the fields of materials science, biotechnology, and medical technology. The business model of Manhattan Scientifics Inc is based on the discovery and development of new technologies, which are then licensed or sold. The company specializes in technology development and works closely with scientific institutions and researchers around the world. In the past, the company has collaborated closely with NASA and the Los Alamos National Laboratory, and has been able to bring several successful products to market. The various divisions of Manhattan Scientifics Inc include nanotechnology, biotechnology, and medical technology. In the field of nanotechnology, the company has developed advanced technologies for the production of ultralight, highly strong materials. These materials are used in aerospace, construction, and other industries where lightweight and durable materials are needed. The biotechnology division of Manhattan Scientifics Inc focuses on the development of novel therapies for cancer and other diseases. The company has successfully developed a new cancer therapy based on magnetic nanoparticles. These nanoparticles are introduced into the body and attach to cancer cells. They are then attracted and killed by an external magnetic field. Medical technology is another important division of Manhattan Scientifics Inc. The company has developed advanced technologies for the production of medical devices that provide more precise surgeries and treatments. One of Manhattan Scientifics Inc's successful innovations is a device that can precisely target tumors with high-energy radiation to destroy them. Manhattan Scientifics Inc has brought several successful products to market in the past. One example of such a product is the Greenshift Corporation System, which helps reduce emissions from airplanes. The company has also had successful collaborations with NASA on various projects, including the development of super-lightweight carbon fiber components. Overall, Manhattan Scientifics Inc is an innovative company that specializes in the development of new technologies. The company has successfully worked in various fields, including nanotechnology, biotechnology, and medical technology. Its business model is based on the discovery and development of new technologies, which are then licensed or sold. Through its collaborations with scientific institutions and researchers around the world, the company has developed and brought several successful products to market. Manhattan Scientifics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Manhattan Scientifics's Shares Outstanding

Manhattan Scientifics's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Manhattan Scientifics’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Manhattan Scientifics’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Manhattan Scientifics’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Manhattan Scientifics stock

How many stocks are there of Manhattan Scientifics?

The current number of stocks of Manhattan Scientifics is 559.28 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Manhattan Scientifics are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Manhattan Scientifics evolved in recent years?

The number of shares of Manhattan Scientifics has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Manhattan Scientifics as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Manhattan Scientifics?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Manhattan Scientifics pay?

Over the past 12 months, Manhattan Scientifics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Manhattan Scientifics is expected to pay a dividend of 0 USD.

What is the dividend yield of Manhattan Scientifics?

The current dividend yield of Manhattan Scientifics is .

When does Manhattan Scientifics pay dividends?

Manhattan Scientifics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Manhattan Scientifics?

Manhattan Scientifics paid dividends every year for the past 0 years.

What is the dividend of Manhattan Scientifics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Manhattan Scientifics located?

Manhattan Scientifics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Manhattan Scientifics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Manhattan Scientifics from 10/6/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2025.

When did Manhattan Scientifics pay the last dividend?

The last dividend was paid out on 10/6/2025.

What was the dividend of Manhattan Scientifics in the year 2024?

In the year 2024, Manhattan Scientifics distributed 0 USD as dividends.

In which currency does Manhattan Scientifics pay out the dividend?

The dividends of Manhattan Scientifics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Manhattan Scientifics

Our stock analysis for Manhattan Scientifics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Manhattan Scientifics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.